Improved physiological properties of gravity-enforced reassembled rat and human pancreatic pseudo-islets

Journal of Tissue Engineering and Regenerative Medicine

Volumn 11, Issue 1, 2017, Pages 109-120

  Zuellig, R A ^a   Cavallari, G ^b   Gerber, P ^a   Tschopp, O ^a   Spinas, G A ^a   Moritz, W ^c   Lehmann, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c InSphero AG   (Switzerland)

Author keywords

diabetes; hanging drop; islet cell transplantation; pseudo islets; reaggregation; survival

Indexed keywords

CELLS; COPYRIGHTS; CYTOLOGY; DROPS; INSULIN; OXYGEN SUPPLY; PHYSIOLOGY; TISSUE;

CELL TRANSPLANTATION; CULTURE METHODS; GLUCOSE-STIMULATED INSULIN SECRETIONS; HANGING DROPS; ISLET CELL TRANSPLANTATION; ISLET CELLS; PSEUDO-ISLET; RAT ISLETS; RE-AGGREGATION; SURVIVAL;

RATS;

INSULIN; GLUCOSE; OXYGEN;

ANIMAL TISSUE; ARTICLE; CELL COMPOSITION; CELL CULTURE TECHNIQUE; CONTROLLED STUDY; HANGING DROP CULTURE METHOD; HUMAN; HUMAN TISSUE; INSULIN RELEASE; MALE; NONHUMAN; ORGAN SIZE; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET DELTA CELL; PRIORITY JOURNAL; PSEUDO ISLET; RAT; ANIMAL; CELL AGGREGATION; CELL CULTURE; CHEMISTRY; CYTOLOGY; GRAFT SURVIVAL; GRAVITY; LEWIS RAT; PANCREAS ISLET BETA CELL; PERFUSION; PROCEDURES;

ANIMALS; CELL AGGREGATION; CELL CULTURE TECHNIQUES; CELLS, CULTURED; GLUCOSE; GRAFT SURVIVAL; GRAVITATION; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; OXYGEN; PERFUSION; RATS; RATS, INBRED LEW;

EID: 84899042567     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1891     Document Type: Article

References (48)

1. Bennet W, Sundberg B, Groth CG et al. 1999; Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48: 1907–1914.
2. Callewaert H, Gysemans C, Cardozo AK et al. 2007; Cell loss during pseudoislet formation hampers profound improvements in islet lentiviral transduction efficacy for transplantation purposes. Cell Transpl 16: 527–537.
3. Carlsson PO, Palm F, Andersson A et al. 2001; Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50: 489–495.
4. Caumo A, Luzi L. 2004; First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287: E371–385.
5. Cavallari G, Olivi E, Bianchi F et al. 2012; Mesenchymal stem cells and islet cotransplantation in diabetic rats: improved islet graft revascularization and function by human adipose tissue-derived stem cells preconditioned with natural molecules. Cell Transpl 21: 2771–2781.
6. Cavallari G, Zuellig RA, Lehmann R et al. 2007; Rat pancreatic islet size standardization by the ‘hanging drop’ technique. Transpl Proc 39: 2018–2020.
7. Davalli AM, Ogawa Y, Ricordi C et al. 1995; A selective decrease in the β-cell mass of human islets transplanted into diabetic nude mice. Transplantation 59: 817–820.
8. Farilla L, Bulotta A, Hirshberg B et al. 2003; Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144: 5149–5158.
9. Fernandez LA, Hatch EW, Armann B et al. 2005; Validation of large particle flow cytometry for the analysis and sorting of intact pancreatic islets. Transplantation 80: 729–737.
10. Fraga DW, Sabek O, Hathaway DK et al. 1998; A comparison of media supplement methods for the extended culture of human islet tissue. Transplantation 65: 1060–1066.
11. Giuliani M, Moritz W, Bodmer E et al. 2005; Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia. Cell Transpl 14: 67–76.
12. Gotoh M, Maki T, Kiyoizumi T et al. 1985; An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437–438.
13. Halban PA, Powers SL, George KL et al. 1987; Spontaneous reassociation of dispersed adult rat pancreatic islet cells into aggregates with three-dimensional architecture typical of native islets. Diabetes 36: 783–790.
14. Heuser M, Wolf B, Vollmar B et al. 2000; Exocrine contamination of isolated islets of Langerhans deteriorates the process of revascularization after free transplantation. Transplantation 69: 756–761.
15. Jones GL, Juszczak MT, Hughes SJ et al. 2007; Time course and quantification of pancreatic islet revascularization following intraportal transplantation. Cell Transpl 16: 505–516.
16. Kampf C, Mattsson G, Carlsson PO. 2006; Size-dependent revascularization of transplanted pancreatic islets. Cell Transpl 15: 205–209.
17. Kelm JM, Timmins NE, Brown CJ et al. 2003; Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83: 173–180.
18. Kempf MC, Andres A, Morel P et al. 2005; Logistics and transplant coordination activity in the GRAGIL Swiss–French multicenter network of islet transplantation. Transplantation 79: 1200–1205.
19. Keymeulen B, Korbutt G, De Paepe M et al. 1996; Long-term metabolic control by rat islet grafts depends on the composition of the implant. Diabetes 45: 1814–1821.
20. Kim SC, Han DJ, Kim IH et al. 2005; Comparative study on biologic and immunologic characteristics of the pancreas islet cell between 24 °C and 37 °C culture in the rat. Transpl Proc 37: 3472–3475.
21. King AJ, Fernandes JR, Hollister-Lock J et al. 2007; Normal relationship of β- and non-β-cells not needed for successful islet transplantation. Diabetes 56: 2312–2318.
22. Korsgren O, Lundgren T, Felldin M et al. 2008; Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 51: 227–232.
23. Korsgren O, Nilsson B, Berne C et al. 2005; Current status of clinical islet transplantation. Transplantation 79: 1289–1293.
24. Lee DY, Park SJ, Nam JH et al. 2008; Optimal aggregation of dissociated islet cells for functional islet-like cluster. J Biomater Sci Polym Edn 19: 441–452.
25. Lehmann R, Spinas GA, Moritz W et al. 2008; Has time come for new goals in human islet transplantation? Am J Transpl 8: 1096–1100.
26. Lehmann R, Zuellig RA, Kugelmeier P et al. 2007; Superiority of small islets in human islet transplantation. Diabetes 56: 594–603.
27. Liang Y, Najafi H, Matschinsky FM. 1990; Glucose regulates glucokinase activity in cultured islets from rat pancreas. J Biol Chem 265: 16863–16866.
28. MacGregor RR, Williams SJ, Tong PY et al. 2006; Small rat islets are superior to large islets in in vitro function and in transplantation outcomes. Am J Physiol Endocrinol Metab 290: E771–779.
29. Matta SG, Wobken JD, Williams FG et al. 1994; Pancreatic islet cell reaggregation systems: efficiency of cell reassociation and endocrine cell topography of rat islet-like aggregates. Pancreas 9: 439–449.
30. Menger MD, Jaeger S, Walter P et al. 1989; Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 38(suppl 1): 199–201.
31. O'Sullivan ES, Johnson AS, Omer A et al. 2010; Rat islet cell aggregates are superior to islets for transplantation in microcapsules. Diabetologia 53: 937–945.
32. Porrett PM, Yeh H, Frank A et al. 2007; Availability of suitable islet donors in the United States. Transplantation 84: 280–282.
33. Potter SW, Morris JE. 1985; Development of mouse embryos in hanging drop culture. Anat Rec 211: 48–56.
34. Ramachandran K, Williams SJ, Huang HH et al. 2013; Engineering islets for improved performance by optimized reaggregation in a micromold. Tissue Eng A 19: 604–612.
35. Reffet S, Thivolet C. 2006; Immunology of pancreatic islet transplantation. Diabetes Metab 32: 523–526.
36. Ryan EA, Lakey JR, Rajotte RV et al. 2001; Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50: 710–719.
37. Shapiro AM. 2011; State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diabetes Rep 11: 345–354.
38. Shapiro AM, Lakey JR, Ryan EA et al. 2000; Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230–238.
39. Shapiro AM, Ricordi C, Hering BJ et al. 2006; International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355: 1318–1330.
40. Shizuru J, Trager D, Merrell RC. 1985; Structure, function, and immune properties of reassociated islet cells. Diabetes 34: 898–903.
41. Spinas GA, Laffranchi R, Francoys I et al. 1998; The early phase of glucose-stimulated insulin secretion requires nitric oxide. Diabetologia 41: 292–299.
42. Su Z, Xia J, Shao W et al. 2010; Small islets are essential for successful intraportal transplantation in a diabetes mouse model. Scand J Immunol 72: 504–510.
43. Tanaka H, Tanaka S, Sekine K et al. 2013; The generation of pancreatic β-cell spheroids in a simulated microgravity culture system. Biomaterials 34: 5785–5791.
44. Thomas F, Wu J, Contreras JL et al. 2001; A tripartite anoikis-like mechanism causes early isolated islet apoptosis. Surgery 130: 333–338.
45. Tsang WG, Zheng T, Wang Y et al. 2007; Generation of functional islet-like clusters after monolayer culture and intracapsular aggregation of adult human pancreatic islet tissue. Transplantation 83: 685–693.
46. Wolf-Jochim M, Wohrle M, Federlin K et al. 1995; Comparison of the survival of fresh or cultured pancreatic islets, pseudoislets and single cells following allotransplantation beneath the kidney capsule in non-immunosuppressed diabetic rats. Exp Clin Endocrinol Diabetes 103(suppl 2): 118–122.
47. Yi P, Park JS, Melton DA. 2013; Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 153: 747–758.
48. Yoon BS, Yoo SJ, Lee JE et al. 2006; Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differ Res Biol Diversity 74: 149–159.